Evidence map›Paper›PMID 30891036›Full record

ArticleFrontiers in immunology2019

Reduced CD27

Chathyan Pararasa, Na Zhang, Thomas J Tull, Ming H A Chong, Jacqueline H Y Siu, William Guesdon, Konstantia Maria Chavele, Jeremy D Sanderson, Louise Langmead, Klaartje Kok and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Human intestinal B cells in inflammatory diseases.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Curcumin alleviates experimental colitisWorld journal of gastroenterology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Chathyan PararasaPeter Gorer Department of Immunobiology, King's College London, Guy's Hospital, London, United Kingdom.
Na ZhangPeter Gorer Department of Immunobiology, King's College London, Guy's Hospital, London, United Kingdom.
Thomas J TullPeter Gorer Department of Immunobiology, King's College London, Guy's Hospital, London, United Kingdom.
Ming H A ChongBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University London, London, United Kingdom.
Jacqueline H Y SiuDepartment of Surgery, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom.
William GuesdonPeter Gorer Department of Immunobiology, King's College London, Guy's Hospital, London, United Kingdom.
Konstantia Maria ChavelePeter Gorer Department of Immunobiology, King's College London, Guy's Hospital, London, United Kingdom.
Jeremy D SandersonDepartment of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Louise LangmeadDepartment of Gastroenterology, Royal London Hospital, Barts Health, London, United Kingdom.
Klaartje KokDepartment of Gastroenterology, Royal London Hospital, Barts Health, London, United Kingdom.
Jo SpencerPeter Gorer Department of Immunobiology, King's College London, Guy's Hospital, London, United Kingdom.
Anna VossenkamperBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University London, London, United Kingdom.
King's College London · GBBarts Health NHS Trust · GBGuy's Hospital · GBQueen Mary University of London · GBGuy's and St Thomas' NHS Foundation Trust · GBObstetrics and Gynecology Hospital of Fudan University · CNUniversity of Cambridge · GB

Funding

Medical Research Council MR/L009382/1Medical Research Council MR/P021964/1Medical Research Council MR/R000964/1
6 · The paper itself

Abstract

The intestinal mucosa in inflammatory bowel disease (IBD) contains increased frequencies of lymphocytes and a disproportionate increase in plasma cells secreting immunoglobulin (Ig)G relative to other isotypes compared to healthy controls. Despite consistent evidence of B lineage cells in the mucosa in IBD, little is known of B cell recruitment to the gut in IBD. Here we analyzed B cells in blood of patients with Crohn's disease (CD) and ulcerative colitis (UC) with a range of disease activities. We analyzed the frequencies of known B cell subsets in blood and observed a consistent reduction in the proportion of CD27

Indexed as

AdultAntibodies, Monoclonal, HumanizedBiopsyB-Lymphocyte SubsetsColitis, UlcerativeCrohn DiseaseFemaleGastrointestinal AgentsHumansImmunoglobulin DInfliximabInterleukin-10Intestinal MucosaMalePeyer's PatchesSeverity of Illness IndexAntibodies, Monoclonal, HumanizedGastrointestinal AgentsIL10 protein, humanImmunoglobulin DInfliximabInterleukin-10TNF protein, humanTumor Necrosis Factor-alphaTumor Necrosis Factor Receptor Superfamily, Member 7UstekinumabvedolizumabbiologicsGALTinflammatory bowel diseaseinfliximabmass cytometrymemory B cellsustekinumab

Identifiers

PMID30891036
PMCPMC6411645
OpenAlexW2916390096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.